Radiation Therapy After Prostate Surgery Offers No Benefit
Study findings suggest that many men can be spared radiation therapy following radical prostatectomy for high-risk prostate cancer.
All articles by Jody Charnow
Upfront Antiandrogens, Chemotherapy for mCRPC Offer Similar Survival
Men who receive first-line abiraterone or enzalutamide or first-line docetaxel treatment for metastatic castration-resistant prostate cancer have similar overall survival, a prospective, observational cohort study found.
Next post in Prostate Cancer
